Skip to main content
SpringerLink
Log in

Welche Substanz ist geeignet?

Schweres Asthma bronchiale: Biologika gezielt auswählen

  • Aktuell
  • Published:
Pneumo News Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Menzies-Gow A et al. Lancet Respir Med. 2023;11(5):425-38

  2. Baastrup Soendergaard M et al. J Allergy Clin Immunol Pract. 2024;12:146-155.e5

  3. Brusselle G et al. Respirology. 2023;28;696-8

  4. Wechsler ME et al. N Engl J Med. 2024; https://doi.org/ 10.1056/NEJMoa2311155

  5. Lommatzsch M et al. S2k-Leitlinie zur fachärztlichen Diagnostik und Therapie von Asthma 2023. Pneumologie. 2023;77:461-543

Download references

Author information

Authors and Affiliations

  1. Springer Medizin Verlag GmbH, Aschauer Str. 30, 81549, München, Deutschland

    Nicola Zink

Authors
  1. Nicola Zink
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zink, N. Schweres Asthma bronchiale: Biologika gezielt auswählen. Pneumo News 16, 46–47 (2024). https://doi.org/10.1007/s15033-024-3993-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15033-024-3993-y

Search

Navigation